Cencora ROA 2012-2026 | COR
Current and historical return on assets (ROA) values for Cencora (COR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Cencora ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-03-31 | $2.55B | $77.64B | 3.28% |
| 2025-12-31 | $1.63B | $75.03B | 2.17% |
| 2025-09-30 | $1.55B | $72.70B | 2.14% |
| 2025-06-30 | $1.90B | $70.33B | 2.70% |
| 2025-03-31 | $1.69B | $68.53B | 2.47% |
| 2024-12-31 | $1.40B | $66.70B | 2.09% |
| 2024-09-30 | $1.51B | $65.61B | 2.30% |
| 2024-06-30 | $1.86B | $64.47B | 2.88% |
| 2024-03-31 | $1.85B | $63.07B | 2.94% |
| 2023-12-31 | $1.87B | $61.80B | 3.02% |
| 2023-09-30 | $1.75B | $60.10B | 2.91% |
| 2023-06-30 | $1.69B | $58.60B | 2.88% |
| 2023-03-31 | $1.62B | $57.60B | 2.81% |
| 2022-12-31 | $1.73B | $57.24B | 3.02% |
| 2022-09-30 | $1.70B | $57.16B | 2.97% |
| 2022-06-30 | $1.84B | $57.35B | 3.21% |
| 2022-03-31 | $1.73B | $57.04B | 3.03% |
| 2021-12-31 | $1.61B | $54.46B | 2.96% |
| 2021-09-30 | $1.54B | $51.53B | 2.99% |
| 2021-06-30 | $-3.74B | $48.26B | -7.76% |
| 2021-03-31 | $-3.75B | $44.48B | -8.42% |
| 2020-12-31 | $-3.22B | $43.24B | -7.45% |
| 2020-09-30 | $-3.41B | $41.78B | -8.16% |
| 2020-06-30 | $1.57B | $40.51B | 3.88% |
| 2020-03-31 | $1.58B | $39.93B | 3.96% |
| 2019-12-31 | $0.65B | $39.12B | 1.66% |
| 2019-09-30 | $0.86B | $38.93B | 2.20% |
| 2019-06-30 | $0.96B | $38.56B | 2.48% |
| 2019-03-31 | $0.93B | $38.52B | 2.41% |
| 2018-12-31 | $1.19B | $38.41B | 3.10% |
| 2018-09-30 | $1.66B | $37.69B | 4.40% |
| 2018-06-30 | $1.08B | $37.10B | 2.91% |
| 2018-03-31 | $0.85B | $36.18B | 2.36% |
| 2017-12-31 | $0.98B | $35.18B | 2.78% |
| 2017-09-30 | $0.36B | $34.57B | 1.05% |
| 2017-06-30 | $0.85B | $34.15B | 2.50% |
| 2017-03-31 | $1.15B | $33.47B | 3.45% |
| 2016-12-31 | $1.35B | $32.99B | 4.08% |
| 2016-09-30 | $1.43B | $32.20B | 4.43% |
| 2016-06-30 | $1.64B | $30.78B | 5.34% |
| 2016-03-31 | $1.51B | $29.64B | 5.09% |
| 2015-12-31 | $0.39B | $28.27B | 1.39% |
| 2015-09-30 | $-0.14B | $26.80B | -0.51% |
| 2015-06-30 | $-0.43B | $25.19B | -1.72% |
| 2015-03-31 | $-0.66B | $23.52B | -2.81% |
| 2014-12-31 | $0.03B | $21.86B | 0.15% |
| 2014-09-30 | $0.27B | $20.58B | 1.33% |
| 2014-06-30 | $0.26B | $19.93B | 1.30% |
| 2014-03-31 | $0.44B | $18.91B | 2.33% |
| 2013-12-31 | $0.31B | $17.85B | 1.71% |
| 2013-09-30 | $0.43B | $16.78B | 2.59% |
| 2013-06-30 | $0.55B | $15.91B | 3.43% |
| 2013-03-31 | $0.56B | $15.70B | 3.56% |
| 2012-12-31 | $0.73B | $15.58B | 4.65% |
| 2012-09-30 | $0.72B | $15.70B | 4.57% |
| 2012-06-30 | $0.70B | $15.59B | 4.50% |
| 2012-03-31 | $0.71B | $15.37B | 4.59% |
| 2011-12-31 | $0.71B | $15.13B | 4.67% |
| 2011-09-30 | $0.71B | $14.66B | 4.81% |
| 2011-06-30 | $0.70B | $14.53B | 4.82% |
| 2011-03-31 | $0.68B | $14.31B | 4.74% |
| 2010-12-31 | $0.65B | $14.10B | 4.58% |
| 2010-09-30 | $0.64B | $13.95B | 4.56% |
| 2010-06-30 | $0.63B | $13.74B | 4.55% |
| 2010-03-31 | $0.58B | $13.42B | 4.33% |
| 2009-12-31 | $0.54B | $13.10B | 4.14% |
| 2009-09-30 | $0.50B | $12.86B | 3.91% |
| 2009-06-30 | $0.49B | $12.52B | 3.90% |
| 2009-03-31 | $0.26B | $12.33B | 2.12% |
| 2008-12-31 | $0.25B | $12.34B | 2.04% |
| 2008-09-30 | $0.25B | $12.35B | 2.03% |
| 2008-06-30 | $0.22B | $12.37B | 1.81% |
| 2008-03-31 | $0.46B | $12.60B | 3.67% |
| 2007-12-31 | $0.46B | $12.85B | 3.56% |
| 2007-09-30 | $0.47B | $12.96B | 3.62% |
| 2007-06-30 | $0.50B | $13.08B | 3.85% |
| 2007-03-31 | $0.49B | $13.07B | 3.76% |
| 2006-12-31 | $0.49B | $12.87B | 3.82% |
| 2006-09-30 | $0.47B | $12.75B | 3.66% |
| 2006-06-30 | $0.37B | $12.40B | 2.94% |
| 2006-03-31 | $0.34B | $12.04B | 2.83% |
| 2005-12-31 | $0.31B | $11.75B | 2.65% |
| 2005-09-30 | $0.27B | $11.43B | 2.32% |
| 2005-06-30 | $0.34B | $11.50B | 2.93% |
| 2005-03-31 | $0.37B | $11.71B | 3.14% |
| 2004-12-31 | $0.41B | $11.91B | 3.45% |
| 2004-09-30 | $0.47B | $12.03B | 3.89% |
| 2004-06-30 | $0.50B | $12.13B | 4.09% |
| 2004-03-31 | $0.48B | $12.22B | 3.95% |
| 2003-12-31 | $0.46B | $12.20B | 3.75% |
| 2003-09-30 | $0.44B | $12.23B | 3.61% |
| 2003-06-30 | $0.42B | $12.03B | 3.47% |
| 2003-03-31 | $0.39B | $11.48B | 3.43% |
| 2002-12-31 | $0.37B | $11.05B | 3.35% |
| 2002-09-30 | $0.35B | $10.80B | 3.20% |
| 2002-06-30 | $0.29B | $10.56B | 2.71% |
| 2002-03-31 | $0.23B | $8.68B | 2.63% |
| 2001-12-31 | $0.17B | $6.72B | 2.50% |
| 2001-09-30 | $0.13B | $4.73B | 2.66% |
| 2001-06-30 | $0.12B | $2.77B | 4.26% |
| 2001-03-31 | $0.11B | $2.65B | 4.19% |
| 2000-12-31 | $0.10B | $2.48B | 4.15% |
| 2000-09-30 | $0.10B | $2.33B | 4.25% |
| 2000-06-30 | $0.08B | $2.23B | 3.55% |
| 2000-03-31 | $0.07B | $2.11B | 3.51% |
| 1999-12-31 | $0.07B | $2.01B | 3.48% |
| 1999-09-30 | $0.07B | $1.88B | 3.52% |
| 1999-06-30 | $0.06B | $1.75B | 3.43% |
| 1999-03-31 | $0.06B | $1.66B | 3.37% |
| 1998-12-31 | $0.05B | $1.64B | 3.17% |
| 1998-09-30 | $0.05B | $1.64B | 2.94% |
| 1998-06-30 | $0.06B | $1.68B | 3.68% |
| 1998-03-31 | $0.05B | $1.67B | 3.12% |
| 1997-12-31 | $0.05B | $1.64B | 2.87% |
| 1997-09-30 | $0.05B | $1.53B | 2.94% |
| 1997-06-30 | $0.04B | $1.39B | 3.02% |
| 1997-03-31 | $0.04B | $1.29B | 3.03% |
| 1996-12-31 | $0.04B | $1.18B | 3.22% |
| 1996-09-30 | $0.04B | $1.10B | 3.20% |
| 1996-06-30 | $0.03B | $1.01B | 3.28% |
| 1996-03-31 | $0.03B | $0.95B | 3.60% |
| 1995-12-31 | $0.03B | $0.89B | 3.50% |
| 1995-09-30 | $0.01B | $0.81B | 1.36% |
| 1995-06-30 | $0.00B | $0.78B | 0.13% |
| 1995-03-31 | $-0.18B | $0.57B | -32.40% |
| 1994-12-31 | $-0.19B | $0.36B | -52.43% |
| 1994-09-30 | $-0.21B | $0.18B | -117.85% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $62.409B | $321.333B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |